INC Research Holdings Inc., a leading global Phase I to Phase IV contract research organization, has named JLL as exclusive provider of strategic and transactional real estate services for its portfolio of facilities worldwide.
Headquartered in Raleigh, N.C., INC Research Holdings provides clinical development services for the biopharmaceutical and medical device industry. JLL will assist the company in aligning its office space across six continents with current needs during a period of significant growth.
The assignment will be led by Erika Jean McNeil, senior vice president, along with Paul Glickman and Matthew Astrachan, vice chairmen, all with JLL. The team will work closely with Kevin Brandenburg, vice president, head of corporate services for INC Research.
JLL will advise INC Research Holdings on the most efficient use of space, providing leasing and strategic analytical services to rationalize the portfolio as the company continues to expand. Currently, INC Research has offices in more than 70 major cities, including Hong Kong, London, Beijing, Tokyo, Toronto, Amsterdam, Moscow, Sidney, and Singapore.
“We are excited to take on an assignment of this scope for a global company such as INC Research, which recently completed an IPO and continues to grow at a steady pace,” said McNeil. “The full-service JLL platform, with global reach and a complete array of commercial real estate services, is ideally suited to meet INC Research’s needs.”
INC Research connects customers, clinical research sites and patients to accelerate the delivery of new medicines to the market. During 2014, the company worked with more than 300 biopharmaceutical customers, including 19 of the top 20 biopharmaceutical companies worldwide.